273 related articles for article (PubMed ID: 15665282)
21. The vertebrate Hef ortholog is a component of the Fanconi anemia tumor-suppressor pathway.
Mosedale G; Niedzwiedz W; Alpi A; Perrina F; Pereira-Leal JB; Johnson M; Langevin F; Pace P; Patel KJ
Nat Struct Mol Biol; 2005 Sep; 12(9):763-71. PubMed ID: 16116434
[TBL] [Abstract][Full Text] [Related]
22. Intermediate DNA repair activity associated with the 322delG allele of the fanconi anemia complementation group C gene.
Donahue SL; Lundberg R; Campbell C
J Mol Biol; 2004 Oct; 342(5):1443-55. PubMed ID: 15364573
[TBL] [Abstract][Full Text] [Related]
23. Current knowledge on the pathophysiology of Fanconi anemia: from genes to phenotypes.
Yamashita T; Nakahata T
Int J Hematol; 2001 Jul; 74(1):33-41. PubMed ID: 11530803
[TBL] [Abstract][Full Text] [Related]
24. The Fanconi anemia complementation group C gene (FAC) suppresses transformation of mutant fibroblasts by the SV40 virus.
Liu JM; Poiley J; Devetten M; Kajigaya S; Walsh CE
Biochem Biophys Res Commun; 1996 Jun; 223(3):685-90. PubMed ID: 8687457
[TBL] [Abstract][Full Text] [Related]
25. FANCD2: a branch-point in DNA damage response?
Grompe M
Nat Med; 2002 Jun; 8(6):555-6. PubMed ID: 12042798
[No Abstract] [Full Text] [Related]
26. Tetratricopeptide-motif-mediated interaction of FANCG with recombination proteins XRCC3 and BRCA2.
Hussain S; Wilson JB; Blom E; Thompson LH; Sung P; Gordon SM; Kupfer GM; Joenje H; Mathew CG; Jones NJ
DNA Repair (Amst); 2006 May; 5(5):629-40. PubMed ID: 16621732
[TBL] [Abstract][Full Text] [Related]
27. Biomedicine. D-Day for BRCA2.
Witt E; Ashworth A
Science; 2002 Jul; 297(5581):534. PubMed ID: 12065747
[No Abstract] [Full Text] [Related]
28. [Complex role of the FA proteins in providing genome stability].
Kluzek K; Zdzienicka MZ
Postepy Biochem; 2005; 51(4):387-94. PubMed ID: 16676573
[TBL] [Abstract][Full Text] [Related]
29. Genetic interactions between tumor suppressors Brca1 and p53 in apoptosis, cell cycle and tumorigenesis.
Xu X; Qiao W; Linke SP; Cao L; Li WM; Furth PA; Harris CC; Deng CX
Nat Genet; 2001 Jul; 28(3):266-71. PubMed ID: 11431698
[TBL] [Abstract][Full Text] [Related]
30. Loss of expression of FANCD2 protein in sporadic and hereditary breast cancer.
van der Groep P; Hoelzel M; Buerger H; Joenje H; de Winter JP; van Diest PJ
Breast Cancer Res Treat; 2008 Jan; 107(1):41-7. PubMed ID: 17333336
[TBL] [Abstract][Full Text] [Related]
31. Differential expression of TP53 associated genes in Fanconi anemia cells after mitomycin C and hydroxyurea treatment.
Martinez A; Hinz JM; Gómez L; Molina B; Acuña H; Jones IM; Frias S; Coleman MA
Mutat Res; 2008 Oct; 656(1-2):1-7. PubMed ID: 18647660
[TBL] [Abstract][Full Text] [Related]
32. Embryonic lethality after combined inactivation of Fancd2 and Mlh1 in mice.
van de Vrugt HJ; Eaton L; Hanlon Newell A; Al-Dhalimy M; Liskay RM; Olson SB; Grompe M
Cancer Res; 2009 Dec; 69(24):9431-8. PubMed ID: 19934329
[TBL] [Abstract][Full Text] [Related]
33. Loss of heterozygosity occurs via mitotic recombination in Trp53+/- mice and associates with mammary tumor susceptibility of the BALB/c strain.
Blackburn AC; McLary SC; Naeem R; Luszcz J; Stockton DW; Donehower LA; Mohammed M; Mailhes JB; Soferr T; Naber SP; Otis CN; Jerry DJ
Cancer Res; 2004 Aug; 64(15):5140-7. PubMed ID: 15289317
[TBL] [Abstract][Full Text] [Related]
34. A role for the Fanconi anemia C protein in maintaining the DNA damage-induced G2 checkpoint.
Freie BW; Ciccone SL; Li X; Plett PA; Orschell CM; Srour EF; Hanenberg H; Schindler D; Lee SH; Clapp DW
J Biol Chem; 2004 Dec; 279(49):50986-93. PubMed ID: 15377654
[TBL] [Abstract][Full Text] [Related]
35. Tempol protects against oxidative damage and delays epithelial tumor onset in Fanconi anemia mice.
Zhang QS; Eaton L; Snyder ER; Houghtaling S; Mitchell JB; Finegold M; Van Waes C; Grompe M
Cancer Res; 2008 Mar; 68(5):1601-8. PubMed ID: 18316625
[TBL] [Abstract][Full Text] [Related]
36. Spectrum of FANCA mutations in Italian Fanconi anemia patients: identification of six novel alleles and phenotypic characterization of the S858R variant.
Savino M; Borriello A; D'Apolito M; Criscuolo M; Del Vecchio M; Bianco AM; Di Perna M; Calzone R; Nobili B; Zatterale A; Zelante L; Joenje H; Della Ragione F; Savoia A
Hum Mutat; 2003 Oct; 22(4):338-9. PubMed ID: 12955722
[TBL] [Abstract][Full Text] [Related]
37. The Fanconi anaemia/BRCA pathway.
D'Andrea AD; Grompe M
Nat Rev Cancer; 2003 Jan; 3(1):23-34. PubMed ID: 12509764
[TBL] [Abstract][Full Text] [Related]
38. Genomic instability in mice is greater in Fanconi anemia caused by deficiency of Fancd2 than Fancg.
Reliene R; Yamamoto ML; Rao PN; Schiestl RH
Cancer Res; 2010 Dec; 70(23):9703-10. PubMed ID: 21118969
[TBL] [Abstract][Full Text] [Related]
39. The Fanconi road to cancer.
D'Andrea AD
Genes Dev; 2003 Aug; 17(16):1933-6. PubMed ID: 12893780
[No Abstract] [Full Text] [Related]
40. Post-irradiation phosphorylation of structural maintenance chromosome 1 (SMC1) is independent of the Fanconi protein pathway.
Nahas SA; Lai CH; Gatti RA
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1167-72. PubMed ID: 15752898
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
